Now we know who’s getting 23andMe’s DNA data. Meet Regeneron Pharmaceuticals.

Ever use 23andMe? Your genetic data has just been sold.

23andMe had all the signs of a success story. The unicorn brand became synonymous with consumer-facing genetic testing, went public, and was once valued at $6 billion.

But then, it all came tumbling down. Sales for 23AndMe kits began to fall, attempts to raise new funds hit a wall, the company …

Leave a Reply

Your email address will not be published. Required fields are marked *